NanoEntek, Inc

NanoEntek, Inc is a medical device manufacturer specializing in lab-on-a-chip technology that combines MEMS (microelectromechanical systems) and microfluidics. The company designs and manufactures microfluidic analyzers that perform biological analysis using minimal sample volumes in very short timeframes. Their core technology involves engineering microchannels on plastic or glass microfluid chips to control biofluid flow and execute various diagnostic assays. Key product lines include the FREND™ System (microfluidic immunofluorescence analyzer), EVE™ HT FL (high-throughput fluorescence cell counter), ADAM™ MC Plus (fluorescence cell counter), ADAM™ rWBC HT (residual white blood cell counter), and ADAMII™ CD34 (fluorescence CD34 counter). These instruments are designed for clinical laboratory and life-science research applications, including cell counting, immunoassays, and hematology analysis. NanoEntek maintains a global distribution and partnership network, with presence at major industry trade shows including Analytica and WHX Labs. The company holds multiple FDA 510(k) clearances and patents related to microfluidic technology. Manufacturing and quality standards align with in vitro diagnostics (IVD) regulatory requirements. The company serves clinical laboratories, research institutions, and diagnostic facilities worldwide.